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Alveolar capillary dysplasia withmisalignment of pulmonary veins (ACD/MPV) is a rare, neonatally lethal developmental disorder of the
lung with deﬁning histologic abnormalities typically associated with multiple congenital anomalies (MCA). Using array CGH analysis,
we have identiﬁed six overlapping microdeletions encompassing the FOX transcription factor gene cluster in chromosome
16q24.1q24.2 in patients with ACD/MPVandMCA. Subsequently, we have identiﬁed four different heterozygousmutations (frameshift,
nonsense, and no-stop) in the candidate FOXF1 gene in unrelated patients with sporadic ACD/MPV and MCA. Custom-designed, high-
resolution microarray analysis of additional ACD/MPV samples revealed one microdeletion harboring FOXF1 and two distinct micro-
deletions upstream of FOXF1, implicating a position effect. DNA sequence analysis revealed that in six of nine deletions, both break-
points occurred in the portions of Alu elements showing eight to 43 base pairs of perfect microhomology, suggesting replication error
Microhomology-Mediated Break-Induced Replication (MMBIR)/Fork Stalling and Template Switching (FoSTeS) as a mechanism of their
formation. In contrast to the association of pointmutations in FOXF1with bowel malrotation, microdeletions of FOXF1were associated
with hypoplastic left heart syndrome and gastrointestinal atresias, probably due to haploinsufﬁciency for the neighboring FOXC2 and
FOXL1 genes. These differences reveal the phenotypic consequences of gene alterations in cis.Introduction
Alveolar capillary dysplasia with misalignment of pulmo-
nary veins (ACD/MPV) (Alveolar Capillary Dysplasia,
Congenital; CACD [MIM 265380]) is a rare and lethal
developmental disorder of the lung that affects both
acinar structure and the intrinsic pulmonary vasculature,
producing a constellation of histologic changes that
when present together deﬁne the entity.1 Infants affected
with ACD/MPV develop respiratory distress and severe
pulmonary hypertension within the ﬁrst two days of life,
have no sustained response to supportive measures, and
die of respiratory failure within the ﬁrst month of life,
although longer survivals and later presentations have
been reported.1–10 More than 80% of infants with ACD/
MPV have additional malformations affecting the cardiac,
gastrointestinal, and genitourinary systems. Intestinal
malrotation is the most commonly observed of these
anomalies, and hypoplastic left heart together with hypo-780 The American Journal of Human Genetics 84, 780–791, June 12,plasia or coarctation of the aortic arch are the most
common associated cardiovascular abnormalities.10,11
Almost 200 ACD/MPV cases have been reported in the
literature, approximately 10% having a familial associa-
tion.4–6,10,12–14 The genetic etiology of ACD/MPV has
remained elusive.10 Recently, STRA6 (MIM 610745) has
been implicated in amalformation syndrome that includes
anophthalmia, additional malformations, and develop-
mental lung abnormalities said to be ACD.15 However,
the reported lung changes in children with STRA6 muta-
tions do not include misalignment of pulmonary veins,
the deﬁning histologic feature, and the clinical course is
vastly different than that of ACD/MPV.
We initiated a study of the genetic basis of esophageal
atresia and tracheo-esophageal ﬁstula, ascertaining
patients with malformations of this type, especially those
that were associated with other congenital anomalies. We
carried out an array comparative genomic hybridization
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(CNV) at critical genomic loci, particularly those harboring
genes that were good candidates on the basis of their
already established roles in foregut development in model
organisms.
In the present study, we demonstrate a crucial role for
FOXF1 (MIM 601089) in human lung and intrinsic pulmo-
nary vascular development by identifying inactivating
mutations in patients with ACD/MPV. These patients
have additional congenital malformations that together
deﬁne a syndrome of ACD/MPV, intestinal malrotation,
and urinary tract malformations. We show that patients
with deletions harboring FOXF1 and the neighboring
FOXC2 (MIM 602402) and FOXL1 (MIM 603252) genes
at 16q24.1 have not only ACD/MPV, as expected, but
also distinct malformations comprising congenital heart
defect, in particular hypoplastic left heart syndrome, and
gastrointestinal atresias, including esophageal atresia, as
well as urinary tract malformations and other malforma-
tions.
Subjects and Methods
Subject Recruitment
We obtained DNA samples from probands with ACD/MPV and
their familymembers after obtaining their informedconsent, using
protocols approved by the Institutional Review Board for Human
Subject Research at Baylor College of Medicine (H8712). The
Cambridgeshire 4 Research Ethics Committee, UK, approved the
study of a cohort of patients with esophageal atresia and associated
malformations (reference04/5/022). PatientD2was ascertainedvia
a study of prenatal malformations conducted at Addenbrooke’s
Hospital. This studywasapprovedbyAddenbrooke’sHospital Local
Research Ethics Committee and by Cambridgshire 1 Research
Ethics Committee, UK (reference 08/H0304/).
Histopathology
Histologic slides of lung tissue obtained at autopsy (deletion cases
D1, D3, D4, D8, and all four mutation cases M1–M4) or biopsy
(deletion cases D9 and D10) were reviewed by C.L. for the diag-
nostic histologic features of ACD/MPV. All cases had slides stained
with hematoxylin and eosin, and patient D1 also had elastic tissue
stains.
DNA Isolation
Patients’ genomic DNA was extracted from peripheral blood via
the Puregene DNA isolation kit (Gentra System, Minneapolis,
MN, USA). DNA was extracted from frozen tissue and peripheral
leukocytes via the Puregene DNA Extraction Kit, as well. Alterna-
tively, DNA from parafﬁn blocks was isolated via the QIAGEN
Kit in accordance with the vendor’s instruction or as described
previously.10
Array CGH Analysis
Initial array CGH analysis was performed with the use of a 244K
commercial array (Agilent Technologies, Santa Clara, CA, USA)
in patient D1 and with an Affymetrix GeneChip 6.0 array in
patient D2, in accordance with the manufacturers’ instructions;
no additional pathogenic CNVs were identiﬁed. Chromosomal
microarray analysis was performed with the use of the V6.1The AmBAC-based array (patient D4), V6.3 OLIGO (patients D5 and
D7), and V7.2 OLIGO (patient D3), designed by Baylor Medical
Genetics laboratories and manufactured by Agilent Technology
as previously described.16,17 Array CGH in patient D5 was
performed with the use of the BAC clone SignatureChipWG
whole-genomemicroarray, in patient D6with the use of the Signa-
tureChipOS, a 105K-feature whole-genome microarray (made for
Signature Genomic Laboratories by Agilent Technologies), in
accordance with the manufacturer’s instructions. Patient D5 was
also analyzed with the use of the Affymetrix 250K SNP array.
Whole-genome high-resolution oligonucleotide microarray
CGH analyses in patients D1–D9, for ﬁne mapping of the sizes
and extents of the deletions, and in subject D10, for conﬁrmation
of the deletion, were performed with the NimbleGen array
HG18_WG_CGH_v1 with 385,000 or 2.1M oligonucleotides
(NimbleGen Systems, Madison, WI, USA), in accordance with
the manufacturer’s instructions.
Custom 16q24 region-speciﬁc high-resolution 44K microarrays
were designed with the use of eArray (Agilent Technologies) and
used for CNV screening in 14 mutation-negative patients with
ACD/MPV.
Fluorescence In Situ Hybridization Analysis
Conﬁrmatory ﬂuorescence in situ hybridization (FISH) analysis in
patients D2–D5 was performed via standard procedures.
Long-Range Polymerase Chain Reaction
and DNA Sequencing
Long-range polymerase chain reaction (LR-PCR), performed in
accordance with the manufacturer’s instructions (Takara Bio,
Japan), ampliﬁed the predicted junction fragments from the
breakpoint regions in patients D1–D9. PCR products were puriﬁed
with thePCRPuriﬁcationKit (QIAGEN,Valencia,CA,USA)andbidi-
rectionally sequenced by Sanger di-deoxynucleotide sequencing
(Lone Star Labs, Houston, TX, USA).
Mutation Analysis of the FOXF1 Gene
Overlapping amplicons covering the entire coding region of exons
1 and 2 of FOXF1 were ampliﬁed and sequenced by conventional
Sanger di-deoxynucleotide sequencing (Lone Star Labs, Houston,
TX; Molecular Core Lab, BCM, Houston, TX). DNA sequences
were analyzed by comparison with reference sequence
(NM_001451.2) with the use of Sequencher v4.2 (GeneCodes,
Ann Arbor, MI, USA). None of the identiﬁed mutations was found
in 150 ethnically matched control chromosomes. Individual
primer sequences and PCR conditions are available on request.
Mutation Cloning
A 1482 bp region covering the mutation and an informative
heterozygous (C/G) SNP, rs2078304, in patient M4 was ampliﬁed
by LR-PCR and cloned with the Copy Control Cloning Kit
(Epicenter Biotechnologies, Madison, WI, USA). Clone DNA was
isolated with the Qiprep Miniprep Kit (QIAGEN, Valencia, CA,
USA) and sequenced by conventional Sanger di-deoxynucleotide
sequencing (Lone Star Labs, Houston, TX, USA).
Polymorphic SNP and Microsatellite Marker Analysis
SNP markers rs12596341, rs10660430, rs11398689, rs1364225,
rs1424019, rs9941308, rs58016760, rs1364224, rs1424016,
rs58557724, and rs1064259 and the microsatellite marker
between chr16:84,723,490–84,723,542 were ampliﬁed forerican Journal of Human Genetics 84, 780–791, June 12, 2009 781
parental studies via routine methods with PCR primers obtained
from Sigma (Woodlands, TX, USA). The SNP PCR products were
bidirectionally sequenced (Lone Star Labs, Houston, TX, USA).
The microsatellite amplicons were separated on 8% polyacryl-
amide gels and visualized by ethidium bromide staining. The
loci order, locations, and sequences were obtained from the
UCSC Genome Browser database.
Bioinformatics and In Silico Sequence Analysis
Genomic sequence based on the oligonucleotide coordinates from
the array CGH experiment was downloaded from the UCSC
genome browser (build 36, March 2006) and assembled with the
Sequencher v4.2 software. Interspersed repeat sequences were
analyzed by RepeatMasker.
Results
Initial Array CGH Screening
Using BAC clone and oligonucleotide array CGH, we iden-
tiﬁed overlapping microdeletions in 16q24.1q24.2,
ranging in size from ~100 kb to ~3.5 Mb, in seven patients
referred for high-resolution genome analysis (Figures 1A
and 1C, Table 1). The ﬁrst of these patients (D1) was ascer-
tained through our study of the genetic basis of esophageal
atresia, for which, to date, 80 syndromic cases have been
studied. The remainder were ascertained by queries of data-
bases of patients referred for high-resolution genome anal-
ysis for a variety of reasons. Parental samples were available
in six out of seven patients (not D2). One deletion (D7) was
inherited from a phenotypically abnormal parent; the
remaining ﬁve were de novo, supporting their likely path-
ogenic effect. No deletion CNVs in this genomic region
were found, either in the Database of Genomic Variants
or in the BCM and Signature Genomics databases of over
30,000 patients studied by array CGH. Five of the seven
deletions (D2–D5 and D7) were independently veriﬁed
by FISH analysis (Figure 1D). High-resolution oligonucleo-
tide array CGH (385K or 2.1M NimbleGen) conﬁrmed the
deletions and enabled breakpoint characterization in all
seven cases (Figures 1E and 1F).
The deletions centered around the FOX transcription
factor gene cluster at 16q24.1. All but one harbored
FOXF1, a gene with a role in lung and foregut development
ascertained on the basis of previous studies of mice.18–20
Patient D7 had an ~131 kb deletion encompassing FOXC2
and FOXL1 but not FOXF1.
Clinical Characterization
Of the six patients with chromosomal deletions harboring
FOXF1 (D1–D6), ﬁve (D1 and D3–D6) died from pulmo-
nary insufﬁciency in the ﬁrst two months of life, and the
mother of a sixth (D2) underwent elective termination of
pregnancy at 22 weeks. Three patients (D1, D3, and D4)
had ACD/MPV documented by histopathological exami-
nation (Figure 2A). Two other patients (D5 and D6) had
severe respiratory distress, raising the possibility of ACD/
MPV, but no postmortem examination was performed.782 The American Journal of Human Genetics 84, 780–791, June 12Cardiac malformations were present in ﬁve of the six
patients; two patients (D2 and D4) had a hypoplastic left
heart, and a third (D5) had a small left ventricle. One
patient (D1) manifested esophageal atresia with tracheo-
esophageal ﬁstula, whereas duodenal and anal atresias
were present in another patient (D3). Five patients (D2–
D6) had abnormalities consistent with urinary tract
obstructive lesions, ranging from uretero-pelvocaliectasis
to severe hydronephrosis. The phenotype in patient D7
was clearly distinct from that in the other six patients.
This patient did not have respiratory insufﬁciency in the
neonatal period and was still alive at the age of 3 years,
having presented with atrial septal defect, bilaterally
dilated and tortuous ureters with left hydronephrosis, dia-
stasis recti, and developmental delay (Figure 2A and Table
1). The deletion was inherited from the patient’s mother,
whose sole recognized phenotypic abnormality was the
presence of an umbilical hernia.
Mutation Analysis of the FOXF1 Gene
Two lines of evidence suggested that FOXF1 haploinsufﬁ-
ciency might be responsible for ACD/MPV in our initial
cohort. First, patients with deletions harboring FOXF1
(D1–D6) had a severe respiratory phenotype (conﬁrmed
histologically as ACD/MPV in three cases), whereas
a patient with a deletion harboring FOXC2 and FOXL1
but not FOXF1, patient D7, did not. Second, mice haploin-
sufﬁcient for Foxf1 have abnormal alveolar development,
notwithstanding the fact that the histological changes
are not identical to those of ACD/MPV.18,19 We therefore
sequenced FOXF1 in a cohort of 18 patients with ACD/
MPV and other malformations.10 We identiﬁed four de
novo heterozygous mutations in the coding sequence of
FOXF1 in four unrelated patients with sporadic ACD/
MPV. Patient M1 had a nonsense mutation (c.150C/A;
p.Y50X) in exon 1; patient M2 had a frameshift mutation
(c.775dupT; p.Y259Lfs11X) in exon 1; patient M3 had
a frameshift mutation (c.956_957delTT; p.F319CfsX66)
in exon 2 adding 29 amino acids to the protein, as pre-
dicted by conceptual translation; and patient M4 had
a T/C substitution in the ﬁrst base of the stop codon,
a no-stop mutation (c.1063T/C; p.X355RextX74) adding
73 amino acids to the protein, as predicted by conceptual
translation (Figures 3A–3D). All four patients had associ-
ated malformations, including a partial atrioventricular
canal defect (1/4 cases), patent ductus arteriosus (1/4),
bowel malrotation (3/4), a congenital short bowel (1/4),
an annular pancreas (1/4), and urinary tractmalformations
(3/4) (Table 2).
Custom-Designed Array CGH
We hypothesized that some of the cases of ACD/MPV in
the cohort might be due to whole-gene deletions, as was
seen for patients D1–D6. We therefore designed a 16q24
region-speciﬁc high-resolution 44K oligonucleotide micro-
array and used it to screen the 14 mutation-negative
patients from our ACD cohort. This analysis revealed an, 2009
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Figure 1. Summary of the Results in Patients with Microdeletions in 16q24.1q24.2
(A) Schematic representation of the genomic region harboring the FOX transcription gene cluster, FOXF1, FOXC2, and FOXL1, showing the
extent and gene content of the regions deleted in seven patients analyzed by array CGH (D1–D7). A non-ACD/MPV patient, D7, with a
deletion of FOXC2 and FOXL1 and an intact FOXF1, is also shown.
(B) Microdeletions identified via a custom designed 16q24-specific high-resolution 4344K Agilent array in three patients with ACD/MPV
(D8–D10). Note that the microdeletion in subject D8 contains FOXF1, whereas those in patients D9 and D10 are located upstream of FOXF1,
indicating a position effect on this gene. Group 1 patients are indicated in red, group 2 in blue (see main text for explanation). In six
out of nine deletions analyzed, breakpoints map within Alu repetitive elements, suggesting MMBIR/FoSTeS or NAHR mechanisms of
formation.
(C) Targeted array CGH plot obtained with V7.2 OLIGO (Agilent 105K) in patient D3, showing a deletion in 16q24.1 (red mark designated
by arrow).
(D) Metaphase chromosomes of patient D4 after FISH with a 16q24-specific BAC clone, RP11-542M13 (red), and a control chromosome 16
alfa satellite (Vysis) probe (green), showing absence of signal (arrow) on one chromosome 16, consistent with a heterozygous deletion.
(E and F) NimbleGen whole-genome oligonucleotide array CGH profiles for subjects D3 (E) and D4 (F).
(G) The ~524 kb deletion in patient D9, located ~52 kb upstream of FOXF1, was detected via a custom designed 16q24-specific
high-resolution 4344K Agilent array. Green dots shifted to the left between 84.43–84.95 represent the deleted segment.~1.8 Mb microdeletion harboring FOXF1 in patient D8. In
addition, two microdeletions, one ~524 kb (patient D9)
and one ~145 kb (patient D10) in size, located ~52 kbThe Amand ~259 kb upstream of FOXF1, respectively, were
detected (Figures 1B and 1G, Table 1). All three rearrange-
ments arose de novo.erican Journal of Human Genetics 84, 780–791, June 12, 2009 783
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9Table 1. Summary of the Clinical Findings in Patients with FOX Gene Cluster Microdeletions in 16q24.1q24.2
Patient Deletion M/F Gest. (wks) LS Birth Wt. (g)
Respiratory
Findings
Cardiac
Findings
Gastrointestinal
Findings
Genitourina
Findings
D1 ~1.5 Mb
FOXF1,
FOXC2,
FOXL1
F 28 1 day 1091 ACD/MPV,
pulmonary
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placement of anus
-
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FOXC2,
FOXL1
M 22; TOP N/A NK - HLHS - Dilated ren
D3 ~0.9 Mb
FOXF1,
FOXC2,
FOXL1
M 38;
elective
C-section
40 days 2900 ACD/MPV; persistent
pulmonary
hypertension;
ECMO dependent
(veno-veno)
Tetralogy of Fallot;
PDA
Duodenal atresia with
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imperforate anus
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hydronephr
mod right,
severe left
D4 ~1.0 Mb
FOXF1,
FOXC2,
FOXL1
F 37;
elective
C-section
15 days - ACD/MPV; left
pneumothorax;
hypoxemia;
Surfactant therapy;
ECMO
HLHS - Mild uretero
caliectasis
D5 ~3.5 Mb
FOXF1,
FOXC2,
FOXL1
M - 18 days - ECMO dependent IAA, dilated PA, large
PDA, decreased size
left ventricle,
pulmonary
hypertension
- Bilateral re
pelviectasis
D6 ~103 Kb
FOXF1,
MTHFSD
M 35 5 days 1700 Respiratory distress
requiring inhaled
nitrous oxide,
hydrocortisone,
prostaglandin and
FiO2 100%,
attributed to RDS
AVSD, ostium primum
ASD, small VSD, PDA,
mildly hypoplastic LV,
bicuspid AV,
Possible duodenal
atresia, possible
intestinal malrotation
Moderate b
pelvicaliect
mild to mo
proximal ur
dilatation;
mild to mo
distal urete
dilatation
D7 131 Kb,
FOXC2
and FOXL1
F - Alive at
3 yrs
- - Spontaneous ASD
closing
Diastasis recti
(6 cm at 14 months
of age)
Dilated and
ureters bila
with left
hydronephr
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PA, pulmonary artery; ASD, atrial septal defect; VSD, ventricular septal defect; AVSD atrio-
ndrome; ECMO, extracorporeal membrane oxygenation; PDA, patent ductus arteriosus; RDS,
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Patient Deletion M/F Gest. (wks) LS Birth Wt. (g)
Respiratory
Findings
Cardiac
Findings
Gast
Find
D8a ~1.8 Mb
FOXF1,
FOXC2,
FOXL1
F term 25 days 3676 ACD/MPV; persistent
pulmonary
hypertension; lung
biopsy done
PDA, ligated;
structurally normal
heart by
echocardiogram
Adhe
bowe
part
and
malr
at la
D9 524 Kb,
Upstream
of FOXF1
F term 20 days 3742 ACD/MPV; persistent
pulmonary
hypertension, 2
courses of ECMO
days 2-7 and again
beginning on day 10.
Lung biopsy at 17 days
Multiple normal
echocardiograms
Susp
malr
impe
D10 145 Kb,
Upstream
of FOXF1
F term 13 days 3600 ACD/MPV respiratory
distress with
pulmonary
hypertension,
requiring mechanical
ventilation, HFOV,
inhaled nitric oxide,
ECMO. Lung biopsy
at 12 days
Echocardiogram on
day 2 showed
changes related to
severe pulmonary
hypertension and
small PDA with no
other abnormality
-
Abbreviations are as follows: M, male; F, female; Gest., gestation; LS, lifespan; TOP, elective termination of pregnancy;
ventricular septal defect; LV, left ventricle; AV, aortic valve; IAA, interrupted aortic arch; HLHS, hypoplastic left heart sy
respiratory distress syndrome; HFOV, high frequency oscillatory ventilation; CAL, cafe-au-lait patch.
a This patient was described in Sen et al.10
Figure 2. Histopathology Studies
Histopathology studies show that all deletion and mutation patients have characteristic changes of ACD/MPV, with medial hyperplasia of
small pulmonary arteries, abnormally positioned pulmonary veins adjacent to membranous and terminal bronchioles and coursing with
small pulmonary arteries (misalignment), lobular underdevelopment, and deficient numbers of normally positioned airspace wall capil-
laries with abnormal enlarged and centrally placed thin-walled vascular channels in airspace walls. The deletion cases often show marked
airspace enlargement, thinner airspace walls, and pulmonary lymphangiectasis; these findings are uncommon in mutation cases. Hema-
toxylin and eosin, initial magnification 25x. (A) Patient D3 with FOXF1 deletion. Note two small pulmonary artery branches with moder-
ately thickened smooth muscle (a), an adjacent malpositioned congested pulmonary vein (v), and a dilated lymphatic channel (l) all
located adjacent to a dilated terminal bronchiole (b). In the inset, this same abnormal vascular configuration is seen adjacent to
a membranous bronchiole and the lobular parenchyma is formed of markedly enlarged and simplified airspaces with thinner walls,
compared to mutation cases. (B) Patient D9 with deletion upstream of FOXF1. Small pulmonary arteries (a) have strikingly thickened
medial smooth muscle and only pin-point lumens; they share a common connective tissue sheath with pulmonary vein branches (v)
that are neither dilated nor congested and both are adjacent to a membranous bronchiole (b). Normally positioned capillaries are not
seen in airspace walls, although there are more centrally placed congested thin-walled vascular channels. A prominent lymphatic (l)
is adjacent to the artery/vein combination. Airspaces appear prominently enlarged. (C) Patient M2 with frameshift mutation in exon
1. Multiple thick-walled small pulmonary arteries (a) and dilated congested malpositioned pulmonary veins (v) often share the same
connective tissue sheath adjacent to a small bronchiole. The lobular parenchyma is formed of enlarged, simplified and poorly subdivided
airspaces; however airspace enlargement is less dramatic than in the deletion cases. (D) Patient M3 with frameshift mutation in exon 2.
Thick-walled small pulmonary arteries (a) and adjacent dilated and congested veins (v) are located next to a terminal bronchiole (b). The
lobular parenchyma is underdeveloped with simplified and poorly subdivided airspaces separated by thickened septa in which there are
dilated and congested central vascular channels, but only rare capillaries.Histopathology
Of 14 patients, ten had lung tissue available for histologic
review. All ten showed the constellation of changes
required for thehistologicdiagnosisofACD/MPV(Figure2).
Many also showed other superimposed changes; conse-
quences of respiratory failure and therapeutic support,786 The American Journal of Human Genetics 84, 780–791, June 12,terminal events, postmortem changes, and focal inﬂamma-
tion (rarely). However, these did not obscure the diagnostic
hallmarks of ACD/MPV. Pulmonary lymphangiectasis was
evident in all analyzed deletion cases (D1, D3, D4, and
D8–D10), as well as in one (M2) of four examined patients
with mutations. In the patients with lung biopsy but2009
Figure 3. Genomic and Protein Structure of FOXF1 and DNA Sequencing Chromatograms
Genomic and protein structure of FOXF1 and DNA sequencing chromatograms showing four mutations in the coding sequence of FOXF1
identified in patients with ACD/MPV.
(A) A nonsense mutation c.150C > A; p.Y50X in exon 1 in patient M1.
(B) A frameshift mutation c.775 dupT; p.Y259Lfs11X in exon 1 in subject M2.
(C) A frameshift mutation c.956_957 delTT; p.F319CfsX66 in exon 2 in patient M3.
(D) A no-stop mutation c.1063T> C; p.X355RextX74 in exon 2 in individual M4. The base numbering for the FOXF1 gene refers to A of the
second ATG start codon as position 1 (nucleotide 119 of GenBank accession number NM_001451.2).34without autopsy (D9andD10), information related toother
malformations was based on clinical and/or imaging obser-
vations without pathologic conﬁrmation; for those with
neither lung biopsy nor autopsy (D2, D5, and D6), lung
histology remains unknown and information related to
other malformations is based on clinical and/or imaging
observations only. No pulmonary tissue is available from
patient D7, and that patient remains alive at three years of
age, without respiratory symptomatology.
DNA Sequence Analysis
DNA sequence analysis enabled breakpoint sequencing in
patients D1–D9. This conﬁrmed the deletions and revealed
that in patients D1, D3–D6, and D8, both breakpoints
occurred in the portions of Alu elements showing eight
to 43 base pairs (bp) of perfect microhomology. In patients
D2 and D7, microhomologies of 4 and 3 bp, respectively,
were found, and in patient D9, a 3 bp AGC insertion was
identiﬁed at the junction fragments (Table 3).
Parental Origin of Deletions and Mutation
We investigated, when possible, the parent of origin, and
we showed by microsatellite polymorphism and SNP
studies that the deletions in patients D1, D3, D4, D8, D9,
and D10 are maternal in origin. In patient M4, DNA
sequencing of the cloned PCR product revealed that the
no-stop mutation c.1063T/C was associated with the C
allele inherited from the patient’s father, whereas the G
allele was associated with the wild allele, demonstrating
that the mutation occurred on the paternal chromosome
(Table S1).The AmDiscussion
Our report of deletions and point mutations within the
FOX transcription factor gene cluster at 16q24.1 highlights
the differing phenotypic consequences of gene alterations
in cis. The patients described in this report can be classiﬁed
into three groups on the basis of genotype and phenotype.
Patients in group 1 have deletions that encompass all three
FOX genes in the 16q24.1 cluster—FOXF1, FOXC2, and
FOXL1—as well as MTHFSD (genomic deletions). Group
2 patients have deletions spanning either none (patients
D9 and D10) or some (patients D6 and D7; genic deletions)
but not all of the genes in the FOX cluster. Group 3 patients
comprise those with inactivating point mutations in
FOXF1. All group 1 and group 3 patients with histologic
evaluation had ACD/MPV, but there were consistent differ-
ences in the spectrum of associated malformations
between the two groups. All six group 1 patients had
cardiovascular malformations. These ranged in severity
from patent ductus arteriosus (PDA) (D1, D3, D5, and
D8) through interrupted aortic arch (D5) and tetralogy of
Fallot (D3) to reduced left ventricular size (D5) and hypo-
plastic left heart (D2 and D4). Just one of the four patients
in group 3 (M1) had a cardiac malformation, a partial AV
canal defect, together with PDA. Group 1 patients had
gastrointestinal atresias (esophageal in D1, duodenal and
anal in D3), whereas group 3 patients had intestinal malro-
tation or congenital short bowel. As expected, patients in
group 2 were less readily classiﬁable. Patients with dele-
tions, either upstream of (D9 and D10) or encompassing
(D6) FOXF1, had ACD/MPV; one patient (D7) witherican Journal of Human Genetics 84, 780–791, June 12, 2009 787
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0788 The American Journal of Human Genetics 84, 780–791, Jua downstream deletion encompassing just FOXC2 and
FOXL1 did not. Likewise, malformations occurring in
this group were of group 1 type, such as hypoplastic left
heart and imperforate anus, and group 3 type, such as
intestinal malrotation. Additional malformations not
seen in either group 1 or group 3 occurred in this group:
possible abdominal heterotaxy in patient D6, Chiari mal-
formation and meningeal cysts in patient D7.
We propose that ACD/MPV results from haploinsufﬁ-
ciency of FOXF1 and that the differences in the associated
malformations betweengroups1 and3 relate tohaploinsuf-
ﬁciency for FOXC2 and FOXL1. Pointmutations in FOXC2,
probably leading to its haploinsufﬁciency, are responsible
for lymphoedema-distichiasis syndrome;21,22 a small
proportion of these patients also have congenital heart
defects (6.8% in one series,21 including tetralogy of Fallot
and ventricular septal defect but not hypoplastic left heart).
Mice with targeted inactivation of the orthologous Foxc2
have interrupted aortic arch, as well as defects of the skull
and vertebral column.23,24 Haploinsufﬁciency of FOXL1
in humans has not previously been described. Targeted
disruption of Foxl1 in mice is associated with aberrant
epithelial cell positioning in the small intestine, hyper-
plasia of the gastric mucosa and retarded growth.25–27
MTHFSD is amethylene tetrahydrofolate synthase domain-
containing gene of unknown function.
The lack of intestinal atresia in group 3 suggests that
either FOXC2 or FOXL1may also contribute to this pheno-
type in humans, despite the fact that, inmice, haploinsufﬁ-
ciency for Foxf1 alone is associated with esophageal atresia.
It will be fascinating to determine whether deletions or
inactivating mutations contribute to malformations re-
ported here when they occur in isolation, in particular for
hypoplastic left heart syndrome and intestinalmalrotation,
for which no gene has yet been causally implicated. The
presence of overlapping deletions upstream of the FOX
cluster in two patients (D9 and D10) with ACD/MPV
strongly suggests that critical regulatory sequences are
harbored within the minimal interval, and future work
will focus on the identiﬁcation of any evolutionarily
conserved elementswithin this interval and the elucidation
of their functional role.
Although the abnormal lung phenotype of Foxf1þ/
mice has some overlap with that of ACD/MPV in humans
with alveolarization abnormalities, paucity of alveolar
capillaries and pulmonary lymphangiectasia being com-
mon to both, there is no evidence of MPV, the deﬁning
histologic feature of ACD/MPV, in the mutant mice. Two
different mouse models showed that Foxf1/ embryos
die by 8.5 days postcoitum (dpc) from defects in extraem-
bryonic mesoderm development.18,19,28 Interestingly, in
onemodel, half of the newborn Foxf1þ/mice had reduced
(20% of wild-type) levels of pulmonary Foxf1, died from
pulmonary hemorrhage, and showed severe defects in al-
veolarization and vasculogenesis (lung immaturity, hypo-
plasia) with fusion of the right lung lobes and lobar
arteries, as well as an abnormal gall bladder, narrowing ofne 12, 2009
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.The Athe esophagus and trachea, esophageal atresia with tra-
cheo-esophageal ﬁstula, and defects in liver and lung
repair. The other half of the Foxf1þ/ mice had normal
Foxf1 levels and normal lung morphology, interpreted as
a ‘‘compensation’’ for the alveolarization defect.28 We
suggest that the occurrence of these two distinct popula-
tions of mice is consistent with imprinting of Foxf1, in
which the expression level of Foxf1 in Foxf1þ/ mice is
dependent upon the parent of origin of the normal Foxf1
allele. Supporting this notion, the expression from the
Foxf1 promoter has been shown to be regulated by tissue-
speciﬁc methylation29 and FOXF1 was computationally
predicted to be paternally imprinted in humans.30
However, the facts that all six de novo deletions that we
studied for the parental origin arose on amaternal chromo-
some and onemutation of FOXF1 (in patient M4) occurred
on a paternal chromosome, as well as the observation of
a relatively normal phenotype associated with paternal
uniparental disomy 16,31 argue against FOXF1 imprinting
in humans; nevertheless, a complex tissue-speciﬁc ge-
nomic imprinting cannot be excluded.
Foxf1 has been shown to be downregulated in Shh/
mice, probably through Gli proteins,32 and activated by
bone morphogenetic protein 4 (BMP4).32,33 In Foxf1/þ
mice, a diminished expression of Vegfa, Vegfr2, Bmp-4,
Tbx, Lklf, Fgf-10, Gli3, and Notch-2 has been
found.19,28,34–36 Some of these genes, critical for lung
development, may be mutated in patients with ACD/
MPV without detectable abnormalities in FOXF1.
DNA sequence analysis of the deletion breakpoints in
nine patients (D1–D9) revealed that in six patients (D1,
D3–D6, and D8), both breakpoints map in the portions
of Alu elements showing perfect microhomology (eight
to 43 base pairs) (Table 3), suggesting replication error
MMBIR/FoSTeS as amechanism of their formation.37 Alter-
natively, these deletions might have occurred via nonal-
lelic homologous recombination (NAHR). In patients D2,
D7, and D9, the presence of short microhomologies (D2
and D7) and AGC insertion (D9) at the junction fragments
indicate that these deletions probably arose via nonhomol-
ogous end joining or the MMBIR/FoSTeS mechanism.37
Our data may contribute to a better understanding of the
pathogenesis of malformations seen in patients with the
VACTERL (vertebral, anal, cardiac, tracheo-esophageal,
renal and limb malformations) association (MIM
192350).38 Cardiac malformations, esophageal and anal
atresia, renal and vertebral/axial malformations, and
a single umbilical artery appear to be common to both
VACTERL association and 16q24.1 microdeletion.
However, although lungmalformations have been reported
occasionally in cases of VACTERL association, ACD/MPV
has not been described in this context. We suggest that mi-
crodeletions at 16q24.1 should be considered in cases of
apparent VACTERL association for which there is a severe
respiratory distress and/or neonatal lethality. We propose
that patients with intestinal atresia, isolated diastasis recti,
or umbilical hernia should be screened for mutations andmerican Journal of Human Genetics 84, 780–791, June 12, 2009 789
deletions in FOXL1. Given that FOXF1maps only ~3.7 Mb
from 16qter, we also suggest that a balanced rearrangement
involving 16qter (e.g., submicroscopic subtelomeric recip-
rocal translocation) should be excluded in parents with
an ACD/MPV-affected child from whom no material is
available for testing.
Supplemental Data
Supplemental Data include two tables and can be found with this
article online at http://www.ajhg.org/.
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